» Articles » PMID: 37646564

The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease

Overview
Specialty Gastroenterology
Date 2023 Aug 30
PMID 37646564
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The serum-based endoscopic healing index (EHI) test identifies endoscopic Crohn's disease (CD) activity. Data are lacking on the relationship between EHI with other endpoints. We assessed the relationship between EHI and the simplified Magnetic Resonance Index of Activity.

Materials And Methods: Data were prospectively collected on patients with CD with either an EHI or fecal calprotectin (FCAL) within 90 days of magnetic resonance enterography (MRE). Diagnostic accuracy was assessed using area under the receiver operator characteristics. Proportions with any, severe, and terminal ileum MR inflammation were compared above/below identified thresholds for both EHI and FCAL.

Results: A total of 241 MREs paired to either EHI or FCAL from 155 patients were included. Both EHI and FCAL had similar accuracy to diagnose inflammation (area under the receiver operator characteristics: EHI: 0.635 to 0.651, FCAL: 0.680 to 0.708). Optimal EHI values were 42 and 26 for inflammation on MRE and endoscopy, respectively. Patients with EHI ≥42 (100% vs. 63%, P =0.002), FCAL >50 µg/g (87% vs. 64%, P <0.001) and FCAL >250 µg/g (90% vs. 75%, P =0.02) had higher rates of simplified Magnetic Resonance Index of Activity ≥1 compared with lower values. EHI differentiated ileitis numerically more than FCAL (delta: 24% to 25% vs. 11% to 21%). Patients with FCAL ≥50 µg/g had higher rates of severe inflammation compared with FCAL <50 µg/g (75% vs. 47%, P <0.001), whereas smaller differentiation existed for EHI threshold of 42 (63% vs. 49%, P =0.35).

Conclusion: Both EHI and FCAL were specific in their confirmation of inflammation and disease activity on MRE in patients with CD. However, MRE-detected inflammation was frequently present in the presence of low EHI and FCAL in similar proportions.

Citing Articles

Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn's Disease.

Lorenc-Gora J, Waniczek D, Czuba Z, Kryj M, Lorenc Z, Muc-Wierzgon M Biomolecules. 2025; 15(1).

PMID: 39858510 PMC: 11763748. DOI: 10.3390/biom15010116.


Measures of Gut Inflammation in Patients with Inflammatory Bowel Disease: Are Blood-Based Biomarkers Sufficient?.

Swaminathan A, Day A Dig Dis Sci. 2024; 69(8):2723-2724.

PMID: 39078457 DOI: 10.1007/s10620-024-08567-7.

References
1.
Rokkas T, Portincasa P, Koutroubakis I . Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis. J Gastrointestin Liver Dis. 2018; 27(3):299-306. DOI: 10.15403/jgld.2014.1121.273.pti. View

2.
Bjarnason I . The Use of Fecal Calprotectin in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017; 13(1):53-56. PMC: 5390326. View

3.
Ye L, Cheng W, Chen B, Lan X, Wang S, Wu X . Levels of Faecal Calprotectin and Magnetic Resonance Enterocolonography Correlate with Severity of Small Bowel Crohn's Disease: A Retrospective Cohort Study. Sci Rep. 2017; 7(1):1970. PMC: 5434057. DOI: 10.1038/s41598-017-02111-6. View

4.
Cerrillo E, Beltran B, Pous S, Echarri A, Gallego J, Iborra M . Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score. Inflamm Bowel Dis. 2015; 21(7):1572-9. DOI: 10.1097/MIB.0000000000000404. View

5.
Capozzi N, Ordas I, Fernandez-Clotet A, Castro-Poceiro J, Rodriguez S, Alfaro I . Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's Disease. J Crohns Colitis. 2020; 14(8):1074-1081. DOI: 10.1093/ecco-jcc/jjaa030. View